US2006106113A1PendingUtilityA1

Method of delaying ejaculation

51
Assignee: BAR-OR DAVIDPriority: Mar 16, 2001Filed: Sep 1, 2005Published: May 18, 2006
Est. expiryMar 16, 2021(expired)· nominal 20-yr term from priority
Inventors:David Bar-Or
A61P 15/08A61P 15/00A61K 31/137
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides a method of delaying ejaculation. The method comprises administering an effective amount of a tramadol material to a human male prior to sexual intercourse. The method is particularly useful for treating premature ejaculation.

Claims

exact text as granted — not AI-modified
1 . A method of delaying ejaculation comprising administering an effective amount of a tramadol material to a human male prior to sexual intercourse.  
   
   
       2 . The method of  claim 1  wherein the tramadol material is tramadol or a pharmaceutically-acceptable salt thereof.  
   
   
       3 . The method of  claim 2  wherein the tramadol material is (±) cis-tramadol or a pharmaceutically-acceptable salt thereof.  
   
   
       4 . The method of  claim 3  wherein a dose of from about 10 to about 50 milligrams of the tramadol or the pharmaceutically-acceptable salt thereof is administered to the male.  
   
   
       5 . The method of  claim 4  wherein a dose of from about 15 to about 35 milligrams of the tramadol or the pharmaceutically-acceptable salt thereof is administered to the male.  
   
   
       6 . The method of  claim 5  wherein a dose of about 25 milligrams of the tramadol or the pharmaceutically-acceptable salt thereof is administered to the male.  
   
   
       7 . The method of  claim 3  wherein a (+)-enantiomer of the cis-tramadol or the pharmaceutically-acceptable salt thereof is administered to the male.  
   
   
       8 . The method of  claim 3  wherein a (−)-enantiomer of the cis-tramadol or the pharmaceutically-acceptable salt thereof is administered to the male.  
   
   
       9 . The method of  claim 3  wherein the tramadol material is (±) cis-tramadol hydrochloride.  
   
   
       10 . The method of  claim 9  wherein a dose of from about 10 to about 50 milligrams of the tramadol hydrochloride is administered to the male.  
   
   
       11 . The method of  claim 10  wherein a dose of from about 15 to about 35 milligrams of the tramadol hydrochloride is administered to the male.  
   
   
       12 . The method of  claim 11  wherein a dose of about 25 milligrams of the tramadol hydrochloride is administered to the male.  
   
   
       13 . The method of any one of claims  1 - 12  wherein the tramadol material is administered from about 30 minutes to about 60 minutes prior to sexual intercourse.  
   
   
       14 . The method of any one of claims  1 - 12  wherein the tramadol material is administered orally.  
   
   
       15 . The method of  claim 13  wherein the tramadol material is administered orally.  
   
   
       16 . The method of any one of claims  1 - 12  wherein the male suffers from premature ejaculation.  
   
   
       17 . The method of  claim 13  wherein the male suffers from premature ejaculation.  
   
   
       18 . The method of  claim 14  wherein the male suffers from premature ejaculation.  
   
   
       19 . The method of  claim 15  wherein the male suffers from premature ejaculation.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.